Direct Oral Anticoagulants Versus Warfarin in Morbidly Obese Patients With Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-analysis Article (Faculty180)

cited authors

  • Mhanna, Mohammed; Beran, Azizullah; Al-Abdouh, Ahmad; Sajdeya, Omar; Abdulsattar, Waleed; Srour, Omar; Ayesh, Hazem; Alom, Modar; Khuder, Sadik A; Hamouda, Danae; Assaly, Ragheb

description

  • Direct oral anticoagulants (DOACs) have been increasingly preferred over warfarin; however, The International Society of Thrombosis and Hemostasis recommended avoiding the use of DOACs in morbidly obese patients (body mass index >40 or weight >120 kg) because of limited clinical data.

authors

publication date

  • 2021

published in

start page

  • e531

end page

  • e539

volume

  • 28